Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Divi's Laboratories has informed the stock exchanges that the trading window for dealing in its securities will remain closed from April 01, 2026 until 48 hours after the declaration of its audited financial results for the quarter and financial year ended March 31, 2026. This is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015, meaning directors, designated employees, and their immediate relatives cannot trade in the company's shares during this period. The date of the board meeting to approve the Q4 and full-year FY26 results will be announced separately. This filing is procedural and does not contain any financial numbers or business update.
No direct impact on shareholders or stock price. This is a routine regulatory intimation that signals the upcoming Q4 and FY26 earnings announcement, which investors should watch for as the next material catalyst.